Sunhong Kim
Overview
Explore the profile of Sunhong Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1804
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kim S, Cho J, Park B, Park B, Kim J, Park S, et al.
BMB Rep
. 2021 Jan;
54(5):272-277.
PMID: 33407999
RalBP1 associated EPS domain containing 1 (REPS1) is conserved from Drosophila to humans and implicated in the endocytic system. However, an exact role of REPS1 remains largely unknown. Here, we...
12.
Mok J, Park T, Kim S, Kim D, Choi C, Park J
FASEB J
. 2020 Nov;
35(2):e21179.
PMID: 33184929
Type 2 diabetes mellitus may result from insulin resistance in skeletal muscle. Prokineticin receptor 1 (Prokr1) improves metabolic phenotype in adipose tissue and the cardiovascular system; however, its effects on...
13.
Kim S, Jo S, Cho J, Yu M, Shin H, Kim J, et al.
Mol Cells
. 2020 Nov;
43(11):935-944.
PMID: 33168788
Aryl hydrocarbon receptor nuclear translocator (ARNT) plays an essential role in maintaining cellular homeostasis in response to environmental stress. Under conditions of hypoxia or xenobiotic exposure, ARNT regulates the subset...
14.
Cho J, Kim K, Kim S, Park S, Park B, Kim J, et al.
Cell Death Differ
. 2020 Oct;
28(3):900-914.
PMID: 33110214
The mammalian Target of Rapamycin (mTOR) pathway regulates a variety of physiological processes, including cell growth and cancer progression. The regulatory mechanisms of these signals are extremely complex and comprise...
15.
Park S, Jo S, Kim J, Kim S, Ha J, Hwang J, et al.
Cancers (Basel)
. 2020 Sep;
12(9).
PMID: 32906688
Enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2), the catalytic subunit of polycomb repressive complex 2 (PRC2), regulates genes involved in cell lineage and differentiation through methylating lysine...
16.
Kim K, Park S, Park B, Kim J, Kim S
BMB Rep
. 2020 Apr;
53(7):373-378.
PMID: 32317083
Phosphorylation of the signaling component by protein kinase often leads to a kinase cascade or feedback loop. 3-Phosphoinositide- dependent kinase 1 (PDK1) signaling pathway diverges into various kinases including Akt...
17.
Lee S, Jamil B, Kim S, Choi Y
Sensors (Basel)
. 2020 Feb;
20(4).
PMID: 32098252
Myoelectric prostheses assist users to live their daily lives. However, the majority of users are primarily confined to forearm amputees because the surface electromyography (sEMG) that understands the motion intents...
18.
Disordered region of cereblon is required for efficient degradation by proteolysis-targeting chimera
Kim K, Lee D, Park S, Jo S, Ku B, Park S, et al.
Sci Rep
. 2019 Dec;
9(1):19654.
PMID: 31873151
Proteolysis targeting chimeras (PROTACs) are an emerging strategy for promoting targeted protein degradation by inducing the proximity between targeted proteins and E3 ubiquitin ligases. Although successful degradation of numerous proteins...
19.
Jang H, Park S, Kim J, Kim J, Kim S, Cho S, et al.
Mol Cells
. 2019 Dec;
43(1):23-33.
PMID: 31870133
NF-κB signaling through both canonical and non-canonical pathways plays a central role in immune responses and inflammation. NF-κB-inducing kinase (NIK) stabilization is a key step in activation of the non-canonical...
20.
Kim S, Go A, Jo S, Park S, Jeon Y, Kim J, et al.
Eur J Med Chem
. 2019 Jan;
166:65-74.
PMID: 30684871
Immunomodulatory drugs (IMiDs) exert anti-myeloma activity by binding to the protein cereblon (CRBN) and subsequently degrading IKZF1/3. Recently, their ability to recruit E3 ubiquitin ligase has been used in the...